Provided by Tiger Trade Technology Pte. Ltd.

PharmaCyte Biotech, Inc.

0.7412
+0.04125.89%
Post-market: 0.80000.0588+7.93%18:15 EST
Volume:97.67K
Turnover:72.56K
Market Cap:7.51M
PE:-0.67
High:0.7982
Open:0.7400
Low:0.6951
Close:0.7000
52wk High:1.90
52wk Low:0.6300
Shares:10.13M
Float Shares:8.93M
Volume Ratio:0.34
T/O Rate:1.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1141
EPS(LYR):3.19
ROE:-17.68%
ROA:-4.76%
PB:0.21
PE(LYR):0.23

Loading ...

Director Jonathan Schechter Acquires Common Shares of PharmaCyte Biotech Inc

Reuters
·
Jan 08

PharmaCyte Biotech Delays Quarterly Financial Filing

Reuters
·
Dec 16, 2025

PharmaCyte Biotech Inc - Receives Notice of Non-Compliance With Nasdaq Rule - SEC Filing

THOMSON REUTERS
·
Dec 06, 2025

PharmaCyte Biotech : Will Consider All Available Options to Regain Compliance, Including, IF Appropriate, Implementing Reverse Stock Split

THOMSON REUTERS
·
Dec 06, 2025

PharmaCyte Biotech Faces Nasdaq Delisting Risk Over Bid Price Rule Compliance

Reuters
·
Dec 06, 2025

PharmaCyte sells Femasys stake, sees cash position rising to $20M

TIPRANKS
·
Nov 25, 2025

PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment

THOMSON REUTERS
·
Nov 25, 2025

PharmaCyte Biotech Inc: Plans to Continue Pursuing Value-Accretive Investment Opportunities

THOMSON REUTERS
·
Nov 25, 2025

PharmaCyte Biotech Issues Correction to Financial Statements

Reuters
·
Nov 19, 2025

PharmaCyte Biotech Inc. held a special shareholder meeting

Reuters
·
Nov 01, 2025

PharmaCyte Biotech Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Sep 25, 2025

PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY

Benzinga
·
Sep 16, 2025

PharmaCyte Biotech Inc. Plans Name Change Following Investment in LightSolver Technology

Reuters
·
Sep 06, 2025

PharmaCyte Biotech Inc - Increases Stake in Tnf Pharmaceuticals by $3 Mln

THOMSON REUTERS
·
Sep 02, 2025

PharmaCyte Biotech Inc. Anticipates Name Change Following TNF Pharmaceuticals Stake Increase

Reuters
·
Sep 02, 2025

Press Release: PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications

Dow Jones
·
Sep 02, 2025

PharmaCyte Biotech Inc. Expands Financial Flexibility with $7 Million Financing to Support Strategic Growth

Reuters
·
Aug 20, 2025

PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing

THOMSON REUTERS
·
Aug 20, 2025

PharmaCyte Biotech Secures $7 Million Through Private Placement Led by Existing Investors

Reuters
·
Aug 18, 2025

PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors

THOMSON REUTERS
·
Aug 18, 2025